Regulatory

Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

The collaboration aims to drive long-term brain monitoring and neurostimulation innovations into clinical applications....

BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...

Womens Wellness brand NUA Raises Rs 35 Crore in Pre-Series C led by Mirabilis Investment Trust

● Round also saw participation from notable investors including Samir Singh, EVP - Asia, Colgate Palmolive & Former Chair of Unilever SE Asia, Shuchi Kothari, Head of DSP Family Office and SRF Limited ● Company turned profitable in Q2 FY24-25 and crossed Rs. 100 Cr net revenue ARR in Q3 ● Company aims to clock Rs. 150 Cr net revenue ARR in the next quarter. ● Funds raised will be deployed for retail expansion and new product introduction across key channels ...

EyeYon Medical expands operations with New Subsidiary in China

The move aims to strengthen EyeYon’s presence in Asia and enhance access to its innovative ophthalmic solutions....

FDA approves Roche’s Susvimo as first continuous delivery treatment for Diabetes-Related Blindness

Susvimo becomes the only FDA-approved therapy offering continuous drug delivery for diabetic eye disease....

Gyder Surgical secures FDA 510(k) clearance for GYDER® Hip System

World’s first pin-less, image-less solution for precise acetabular cup positioning in anterior hip arthroplasty....

Median Technologies' eyonis™ LCS Achieves Primary Endpoint in RELIVE Trial

Successful results from the pivotal study pave the way for regulatory submissions in lung cancer screening....

Intelligent Bio Solutions expands global reach with Drug Screening System upgrade

The enhanced system now supports multiple languages, improving accessibility for global drug screening operations....

QR678® Partners with Spectra Medical to Expand Access Nationwide

The partnership aims to make QR678®'s advanced, non-surgical hair regrowth treatment more accessible across the country through Spectra Medical’s distribution network. ...

Vertex Secures FDA Approval for JOURNAVX™ (suzetrigine), a Novel Non-Opioid Treatment for Acute Pain

JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....